[1]
“Cotrimoxazole as adjuvant therapy in critical ill COVID 19 patients”, J Ideas Health, vol. 3, no. Special1, pp. 196–197, Sep. 2020, doi: 10.47108/jidhealth.Vol3.IssSpecial1.60.